Citi Analyst Gives Westlake Corporation Buy Rating with $94 Price Target
PorAinvest
miércoles, 6 de agosto de 2025, 8:52 pm ET1 min de lectura
MFG--
The company's stock remained stable at $66.21 per share in after-hours trading. Analysts maintained a positive outlook, with Citi's Patrick Cunningham maintaining a Buy rating with a price target of $94.00. Mizuho Securities also issued a Buy rating, while KeyBanc maintained a Hold rating [1].
Westlake Chemical highlighted operational improvements and cost-reduction efforts as part of its ongoing strategy to navigate market challenges. The company implemented a $75 million cost reduction in Q2 2025, with plans for an additional $200 million by 2026. The company's Altman Z-Score of 2.51 and analyst price targets ranging from $75 to $99 indicate moderate financial stability [1].
Key Takeaways:
- Net loss of $12 million in Q2 2025.
- Net sales of $3 billion.
- HIP segment EBITDA of $275 million on $1.2 billion sales.
- Stock price stable at $66.21.
- Analysts maintain positive outlook with Buy ratings from Citi and Mizuho Securities.
Westlake Chemical is navigating a challenging market environment with strategic cost reductions and a focus on long-term growth in its HIP segment. The company's stable stock price reflects investor confidence in its ability to manage current challenges and capitalize on future opportunities.
References:
[1] https://www.investing.com/news/transcripts/earnings-call-transcript-westlake-chemical-reports-q2-2025-net-loss-93CH-4171107
WLK--
WLKP--
Citi analyst Patrick Cunningham maintained a Buy rating on Westlake Corporation with a price target of $94.00. Cunningham has a 36.36% success rate and focuses on Basic Materials stocks. Mizuho Securities also issued a Buy rating, while KeyBanc maintained a Hold. WLK has a market cap of $10.65B and a P/E ratio of -154.54.
Westlake Chemical Corporation (WLK) reported a net loss of $12 million for the second quarter of 2025, driven by soft global manufacturing activity and weak construction trends in the PVC market. Despite the loss, the company achieved $3 billion in net sales, with the HIP segment showing strong performance with $275 million in EBITDA [1].The company's stock remained stable at $66.21 per share in after-hours trading. Analysts maintained a positive outlook, with Citi's Patrick Cunningham maintaining a Buy rating with a price target of $94.00. Mizuho Securities also issued a Buy rating, while KeyBanc maintained a Hold rating [1].
Westlake Chemical highlighted operational improvements and cost-reduction efforts as part of its ongoing strategy to navigate market challenges. The company implemented a $75 million cost reduction in Q2 2025, with plans for an additional $200 million by 2026. The company's Altman Z-Score of 2.51 and analyst price targets ranging from $75 to $99 indicate moderate financial stability [1].
Key Takeaways:
- Net loss of $12 million in Q2 2025.
- Net sales of $3 billion.
- HIP segment EBITDA of $275 million on $1.2 billion sales.
- Stock price stable at $66.21.
- Analysts maintain positive outlook with Buy ratings from Citi and Mizuho Securities.
Westlake Chemical is navigating a challenging market environment with strategic cost reductions and a focus on long-term growth in its HIP segment. The company's stable stock price reflects investor confidence in its ability to manage current challenges and capitalize on future opportunities.
References:
[1] https://www.investing.com/news/transcripts/earnings-call-transcript-westlake-chemical-reports-q2-2025-net-loss-93CH-4171107

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios